EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study

Chunyan Hu iD, Shuangyuan Wang, Hong Lin, Qin Wan, Ruizhi Zheng, Yuanyue Zhu, Mian Li iD, Yu Xu, Min Xu iD, Jie Zheng, Lulu Chen iD, Tianshu Zeng und 40 weitere

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Chunyan Hu und 51 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong Universit…. Hauptthemen laut MEDLINE: Insulin Resistance, Cardiovascular Diseases, Metabolic Syndrome, Obesity. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology of China, Clinical Research Project of Shanghai Municipal Health Commission, Innovative research team of high-level local universities in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To assess the excess risk of cardiovascular disease (CVD) associated with different criteria for metabolic health, and the interplay of body size, insulin sensitivity and metabolic health with CVD risk. Materials and Methods We conducted a prospective study involving 115 638 participants from the China Cardiometabolic Disease and Cancer Cohort (4C) Study. Metabolic health was defined using three different definitions: (1) insulin sensitivity defined by homeostatic model assessment of insulin resistance index; (2) absence of metabolic syndrome according to the National Cholesterol Education Program Adult Treatment Panel III criteria; and (3) simultaneous absence of metabolic abnormalities (diabetes, hypertension, dyslipidaemia). The primary endpoint was a composite of incident CVD events comprising the first occurrence of myocardial infarction, stroke, heart failure, or cardiovascular death.

Results

During a mean 3.61‐year follow‐up period, obese individuals with insulin sensitivity (multivariable‐adjusted hazard ratio [HR] 1.69, 95% confidence interval [CI] 1.37–2.08), or without metabolic syndrome (HR 1.46, 95% CI 1.13–1.89) still exhibited increased CVD risks, when compared to their normal‐weight counterparts. Otherwise, those with obesity but simultaneous absence of metabolic abnormalities demonstrated similar CVD risk compared to normal‐weight individuals (HR 0.91, 95% CI 0.53–1.59). CVD risk increased with the number of abnormalities across body mass index categories, regardless of insulin sensitivity.

Conclusions

This study emphasizes the need for refined definitions of metabolic health and advocates for meticulous screening for metabolic abnormalities to reduce cardiovascular risks, even in individuals with normal weight and insulin sensitivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceCardiovascular DiseasesMetabolic SyndromeObesityBody SizeHumansMaleFemaleChinaMiddle AgedProspective StudiesAdultRisk FactorsAgedNeoplasmsCohort StudiesFollow-Up StudiesEast Asian People

Stichwörter der Autor:innen

body sizecardiovascular diseaseinsulin sensitivitymetabolic statusmetabolically healthy obesityobesity

Autor:innen und Institutionen

  • Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Transl…
  • The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Affiliated Hospital of Guiyang Medical College, Guiyang, China.

ORCID-Profile: Chunyan Hu, Mian Li, Min Xu, Lulu Chen, Yuhong Chen, Xuefeng Yu, Li Yan, Tiange Wang, Guijun Qin, Gang Chen, Tao Yang, Yiming Mu, Jieli Lu

Förderung

  • Ministry of Science and Technology of China
  • Clinical Research Project of Shanghai Municipal Health Commission
  • Innovative research team of high-level local universities in Shanghai
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Hu, C., Wang, S., Lin, H., Wan, Q., Zheng, R., Zhu, Y., Li, M., Xu, Y., Xu, M., Zheng, J., Chen, L., Zeng, T., Hu, R., Ye, Z., Shi, L., Su, Q., Chen, Y., Yu, X., Yan, L., …, & 4C Study Group (2024). Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15525

Vancouver

Hu C, Wang S, Lin H, Wan Q, Zheng R, Zhu Y, et al. Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15525

BibTeX
@article{Hu2024,
  author = {Hu, Chunyan and Wang, Shuangyuan and Lin, Hong and Wan, Qin and Zheng, Ruizhi and Zhu, Yuanyue and Li, Mian and Xu, Yu and Xu, Min and Zheng, Jie and Chen, Lulu and Zeng, Tianshu and Hu, Ruying and Ye, Zhen and Shi, Lixin and Su, Qing and Chen, Yuhong and Yu, Xuefeng and Yan, Li and Wang, Tiange and Zhao, Zhiyun and Qin, Guijun and Chen, Gang and Dai, Meng and Zhang, Di and Tang, Xulei and Gao, Zhengnan and Shen, Feixia and Gu, Xuejiang and Luo, Zuojie and Qin, Yingfen and Chen, Li and Hou, Xinguo and Huo, Yanan and Li, Qiang and Wang, Guixia and Zhang, Yinfei and Liu, Chao and Wang, Youmin and Wu, Shengli and Yang, Tao and Deng, Huacong and Zhao, Jiajun and Mu, Yiming and Lai, Shenghan and Li, Donghui and Ning, Guang and Wang, Weiqing and Hu, Weiguo and Bi, Yufang and Lu, Jieli and 4C Study Group, 4C Study Group},
  title = {Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15525}
}
Kostenlos starten →